Editas Medicine (EDIT) Non-cash Items (2015 - 2023)

Editas Medicine (EDIT) has 9 years of Non-cash Items data on file, last reported at $466.2 million in Q2 2023.

• Non-cash Items for Q2 2023 came in at $466.2 million, up 25363.4% year-over-year; the trailing twelve-month figure through Jun 2023 was $466.2 million (up 25363.4% YoY), and the FY2022 annual result was $401.5 million, down 92.05% from the prior year.
• Non-cash Items rose to $466.2 million in Q2 2023 per EDIT's latest filing, from $236.5 million in the prior quarter.
• Over five years, Non-cash Items peaked at $5.1 billion in Q4 2021 and troughed at $1.3 million in Q2 2021.
• A 5-year average of $580.3 million and a median of $24.5 million in 2019 frame the typical range for Non-cash Items.
• On a YoY basis, Non-cash Items climbed as much as 25363.4% in 2023 and fell as far as 94.02% in 2023.
• A 5-year view of Non-cash Items shows it stood at $26.1 million in 2019, then surged by 543.28% to $167.6 million in 2020, then soared by 2913.88% to $5.1 billion in 2021, then sank by 92.05% to $401.5 million in 2022, then increased by 16.11% to $466.2 million in 2023.
• Business Quant data shows EDIT's Non-cash Items at $466.2 million in Q2 2023, $236.5 million in Q1 2023, and $401.5 million in Q4 2022.